Liposomes Market 2017 Global Trend, Share and Opportunities Forecast To 2022

The Report Provides Essential Information Including Market Data, Segmentation, Market Size, Key Trends, M&A, Product Developments, Industry Forecasts, Corporate Intelligence, And Other Relevant Information

Liposomes Industry


Wiseguyreports.Com Adds “Liposomes -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021” To Its Research Database

Liposomes Market research report gives an insight into global Liposomes market. The report provides market analytics by application, and by therapeutic area. The market is divided by Application into Therapeutic, Cosmetic and Other; and by Therapeutics into Anti fungal, Anticancer, Ophthalmic and Other. The study also provides information regarding products and technologies in the field of Liposomes.

Request for Sample Report @


Liposomes belong to the class of nanosized unilamellar phospholipid bilayer vesicles. These are considered as the most promising and comprehensively studied drug delivery vehicles. The applications of the Liposome-formulated drugs have multiplied over the years and they are now part of cancer treatment and systemic or local fungal infections. The unique features of Liposome-formulated drugs are that they remain biologically inert, biocompatible and restrict the cause of unwanted toxic or antigenic reactions.

They maintain a high level of popularity in the field of drug research. The application of Liposomes have enormously undergone transformations owing to use in the treatment of solid tumors. The tumors are targeted with Liposomes containing bisphosphonate which reduces the tumor associated macrophages. The other important developments such as use of genetic components as therapeutic molecules have further enhanced the scope of Liposomes based therapy. The components of Liposomes present in the lipid-DNA complexes, commonly called lipoplexes, combat with the viral gene transfection systems. The market for liposomes presents attractive growth opportunities, driven by growing demand for increasingly effective drugs in the field of pharmaceuticals, and niche applications in other emerging areas. Liposome drug delivery systems have been instrumental in the formulation of potent drugs to enhance therapeutics. A majority of liposome formulations are designed to bring down toxicity. Presently pharmaceutical products of liposome-based therapeutics exhibit a better understanding of lipid-drug interactions as well as liposome disposition mechanisms. Among these mechanisms are included the impeding of the fast clearance of liposomes.

This is achieved by exercising control over surface hydration, charge and size. Continued improvements of bio-membrane sensors and liposome delivery systems that are competent in the association of other membrane-bound proteins in vivo could allow selective delivery of therapeutic compounds to chosen intracellular target areas. As large quantities of stable and cost-effective liposomes are manufactured many new applications will surface.

Exclusive 25 % flat discount (Offer valid till 31st March 2017) @

Key Players

Advanced Biomedical Ltd. (United Kingdom)

Aradigm Corporation (USA)

Arboretum Skincare (USA)

Arbutus Biopharma (Canada)

Aspen Australia (Australia)

Avanti Polar Lipids, Inc. (USA)

Azaya Therapeutics, Inc. (USA)

BioZone Laboratories, Inc. (USA)

Celsion Corporation (USA)

Chemi SpA (Italy)

Encapsula NanoSciences LLC (USA)

Evonik Industries AG (Germany)

FormuMax Scientific, Inc. (USA)

Gilead Sciences, Inc. (USA)

GP Pharm (Spain)

Guinot (France)

Immunovaccine, Inc. (Canada)

Insmed, Inc. (USA)

Janssen Biotech, Inc. (USA)

KOS Corporation (Japan)

Kuhs GmbH (Germany)

Lifecare Innovations Pvt., Ltd. (India)

Lipoid GmbH (Germany)

Lipotec SA (Spain)

Lippomix, Inc. (USA)

Luye Pharma Group Ltd. (China)

Marina Biotech, Inc. (USA)

Mei Fung International Liposome Limited (Hong Kong)

Merrimack Pharmaceuticals, Inc. (USA)

NOF Corporation (Japan)

Northern Lipids, Inc. (Canada)

Oncothyreon, Inc. (USA)

Pacira Pharmaceuticals, Inc. (USA)

Regulon, Inc. (USA)

Sigma?Tau Pharmaceuticals, Inc. (USA)

Silence Therapeutics plc (United Kingdom)

Spectrum Pharmaceuticals, Inc. (USA)

SynCore Biotechnology Co., Ltd. (Taiwan)

Taiwan Liposome Company, Ltd. (Taiwan)

TTY Biopharm Co., Ltd. (Taiwan)

Valeant Pharmaceuticals International, Inc. (USA)

Why buy this Report

This report may help Strategists, Investors, Laboratories, Contract Research Organizations, Biotechnology & Healthcare Companies, Academic Professionals, Drug Approval Authorities, and Other Organizations to –

  • Identify Market Opportunities
  • Review and Analyze Global and Regional Markets
  • Gauge Market Potential for your Products
  • Identify Competition
  • Use Market Research for exploring new areas
  • Acquire Meaningful Guidelines for Strategic Planning
  • Gear up for Market Entry
  • Get Actionable Information

Analytics and data presented in each report pertain to several parameters such as –

  • Global and Regional Market Sizes, Market Shares, Market Trends
  • Product (Global and Regional) Market Sizes, Market Shares, Market Trends
  • Technology Trends
  • Corporate Intelligence
  • Key Companies By Sales, Brands, Products
  • Other Strategic Business Affecting Data

Buy now @


Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (US)  Ph: +44 208 133 9349 (UK)

Media Contact
Company Name:
Contact Person: Norah Trent
Phone: +1 646 845 9349, +44 208 133 9349
City: New York City
State: NY
Country: United States